Searched for
MANKIND STOCK UPDATE
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Dabur shares tumble 8% after Q2 update signals revenue decline. Should you sell?Shares of Dabur India plummeted 7.8% following an update hinting at a mid-single-digit revenue decline for Q2. Lower primary sales and heav...
- Mankind Pharma to raise Rs 10,000 crore through NCDs, CPs to fund BSV dealThe company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in up to 48 months, according to a regulator...
- Mankind Pharma board approves raising Rs 10,000 crore through NCDsThe board has established a fundraising committee and granted them the authority to manage all aspects of raising funds, such as deciding t...
- Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growthMankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic re...
- Technical Breakout Stocks: How to trade Sobha, Mankind Pharma and Just Dial on FridayThe 30-share Sensex climbed 63 points to settle at 71,721 and the Nifty gained 28 points to 21,647. Sectorally, oil and gas, consumer durab...
- Foreign investor Beige offloads 3.6% stake in Mankind Pharma for Rs 2,460 croreMankind Pharma is majority-owned by promoters at 76.5% stake, while the public owns the remaining 23.5%. Among the public shareholders, mut...
- 3 PE firms looking to sell 5-6% stake in Mankind Pharma via block deals: ReportKotak Mahindra Capital is one of the advisors to the deal, and the private equity investors are offering a discount of upto 7% from the cur...
- Breakout Stocks: How to trade Tata Investment, Mankind Pharma and ITI on TuesdaySectorally, buying was seen in IT, telecom, healthcare and public sector stocks while selling was seen in auto, utilities, capital goods, a...
- United Breweries, IIFL Finance among 5 stocks with RSI trending bearishStock market enthusiasts often rely on tools like the Relative Strength Index (RSI) to gauge stock movements. On November 6, Tuesday, Stock...
- RITES, Sheela Foam among 10 stocks with RSI trending upOn October 13, ETMarkets delved into 10 stocks showcasing a bullish trend with their RSI surging upwards. Discover the essence of Relative ...
- Mankind Pharma, Radico Khaitan among 10 stocks with RSI trending downOn September 7, Thursday, StockEdge identified 8 stocks with declining RSI values, and ETMarkets has chosen to shed light on these stocks. ...
- NMDC, Mankind Pharma among 10 stocks with RSI trending downIn this article, we delve into the intriguing world of stock market analysis, focusing on the Relative Strength Index (RSI) and its signifi...
- Hitachi Energy, Varun Beverages among 10 stocks with RSI trending upOn August 3, Thursday, StockEdge reported 18 stocks trending up, and ETMarkets has singled out 10 promising stocks from the list. This arti...
- Mankind Q1 Results: Net profit zooms 66% YoY to Rs 494 croreThe Delhi-headquartered drugmaker posted Rs 298 crore in the corresponding quarter of the previous year. Revenue rose 18% YoY to Rs 2579 cr...
- Mankind Pharma Q1 Results: PAT soars 66% YoY to Rs 487 crore on strong all-round showOperating profit, calculated as earnings before interest, taxes, depreciation and amortisation (EBITDA) for the quarter surged 43% YoY to R...
- Shriram Finance, Mankind Pharma among 8 overbought stocks with bearish RSIOver 30 stocks were previously trading in the overbought zone but saw a bearish RSI trend. However, ETMarkets reports that 10 stocks are st...
- D-Street newbie Mankind Pharma to be included in Nifty500, Nifty Midcap100 and other indicesMankind Pharma, which recently made its stock exchange debut, has been added to several Nifty indices, including Nifty500 and Nifty Midcap1...
- A full Molnupiravir treatment likely to cost up to Rs 3,000The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will...
Load More
